BIO vs IBEX · rev $2.58B vs P/E 13, rev $558.3M
BIO (BIO) versus IBEX Ltd (IBEX) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
IBEX Ltd (IBEX) is a information technology services company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 287.0% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported IBEX revenue for 2025-06-30 was $558.3M. Net income was $36.9M. IBEX currently screens at market cap $388.5M and trailing P/E 12.9.
BIO currently screens at market cap $0. IBEX currently screens at market cap $388.5M and trailing P/E 12.9.
Not investment advice. Open the BIO and IBEX stock pages for the full models.
Not investment advice.